Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Advocacy at a Glance STEVEN GROSSMAN 1/8/21 Advocacy at a Glance STEVEN GROSSMAN 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/20 Advocacy at a Glance STEVEN GROSSMAN 12/5/20 CDRH Director Presents at Alliance Webinar Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More Advocacy at a Glance STEVEN GROSSMAN 9/25/20 Advocacy at a Glance STEVEN GROSSMAN 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Following the Science to Protect Public Health Read More Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Advocacy at a Glance STEVEN GROSSMAN 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Advocacy at a Glance STEVEN GROSSMAN 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Advocacy at a Glance STEVEN GROSSMAN 1/8/21 Advocacy at a Glance STEVEN GROSSMAN 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 What Will Actually Get Funded at FDA in FY 21? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 12/11/20 Advocacy at a Glance STEVEN GROSSMAN 12/11/20 FDA Commissioner and CBER Director Provide Insights on Vaccines at Alliance Briefing Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/20 Advocacy at a Glance STEVEN GROSSMAN 12/5/20 CDRH Director Presents at Alliance Webinar Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/20 Advocacy at a Glance STEVEN GROSSMAN 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More
Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Advocacy at a Glance STEVEN GROSSMAN 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More
Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Advocacy at a Glance STEVEN GROSSMAN 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More
Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Advocacy at a Glance STEVEN GROSSMAN 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More
Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More
Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More
Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Advocacy at a Glance STEVEN GROSSMAN 10/9/20 Life Under the Continuing Resolution Read More
Advocacy at a Glance STEVEN GROSSMAN 10/2/20 Advocacy at a Glance STEVEN GROSSMAN 10/2/20 FDA to Be Funded under Short-Term Continuing Resolution through December 11 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/25/20 Advocacy at a Glance STEVEN GROSSMAN 9/25/20 FDA Will Begin Fiscal Year 2021 With CR Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Advocacy at a Glance STEVEN GROSSMAN 9/18/20 Dr. Cavazzoni and Dr. Stein to Address FDA Members and Media on October 16 Read More
Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Following the Science to Protect Public Health Read More
Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Advocacy at a Glance STEVEN GROSSMAN 9/11/20 Alliance Webinar with CDER Postponed, Will Be Rescheduled Shortly Read More
